On August 16, 2022, Titan Pharmaceuticals, Inc announced that at its annual general meeting of shareholders held on August 15, 2022, the stockholders elected all of David E Lazar's 6 nominees: Avraham Ben-Tzvi, Peter L. Chasey, Eric Greenberg, David E. Lazar, Matthew C. McMurdo, and David Natan for director to serve until the next annual meeting of stockholders and until their successors are elected and are qualified.